ArticleEye (London, England)2026
The relationship between glycaemic status and the risk of third, fourth and sixth cranial nerve palsy: a nationwide population-based study (2009-2018).
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
Abstract
purposeThe purpose of this study was to evaluate the association between glycaemic status and the incidence of third, fourth, and sixth cranial nerve palsy (CNP).
methodsThis is a retrospective nationwide population-based cohort study using South Korean National Health Insurance Service (NHIS) data since 2009. Health check-up data of 4,067,842 individuals aged from 20 to 90 years in the period from 1 January 2009 to 31 December 2018 were analysed. The subjects were classified according to glycaemic status as follows: non-diabetes, impaired fasting glucose (IFG), newly detected diabetes, diabetes duration <5 years, and diabetes duration ≥5 years. The primary endpoint of this study was the incidence of third, fourth or sixth CNP. Hazard ratio (HR) and 95% confidence interval (CI) of CNP were estimated using Cox proportional hazards regression analysis. In Model 5, we adjusted for age, gender, smoking status, alcohol consumption, physical activity, body mass index, hypertension, dyslipidaemia, and chronic kidney disease.
resultsDuring the follow-up period (mean, 6.3 years), 5835 cases of third, fourth, or sixth CNP were identified with 4,062,007 control cases. In the adjusted model 5, the adjusted HR for third, fourth, and sixth CNP in the IFG group was 1.098 (95% CI 1.030 - 1.171); in the newly detected diabetes group, 1.779 (95% CI 1.587-1.994); in the diabetes duration <5 years group, 1.921 (95% CI 1.731-2.131); and in the diabetes duration ≥5 years group, 2.571 (95% CI 2.343-2.820). Using the Kaplan-Meier curve, the log-rank test demonstrated an increase in the incidence of CNP proportional to the duration of diabetes (p < 0.001).
conclusionsThis large-scale, population-based cohort study suggests that the risk of third, fourth, and sixth CNP significantly increased in patients with IFG and diabetes compared to those with normal glycaemic status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.